ORIC Pharmaceuticals, Inc. (ORIC)

NASDAQ: ORIC · IEX Real-Time Price · USD

11.90

+0.66 (5.87%)

At close: Jul 26, 2024, 4:00 PM

11.66

-0.24 (-2.02%)

After-hours: Jul 26, 2024, 6:05 PM EDT

ORIC Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2017
Selling, General & Admin	26.48	25.61	25.09	22.01	13.42	5.73	Upgrade
Research & Development	87.62	85.17	61.68	56.86	35.92	22.84	Upgrade
Operating Expenses	114.09	110.78	86.77	78.87	49.34	28.57	Upgrade
Operating Income	-114.09	-110.78	-86.77	-78.87	-49.34	-28.57	Upgrade
Interest & Investment Income	12.33	10.08	2.65	0.14	0.31	1.4	Upgrade
Other Non Operating Income (Expenses)	-	-	-	0.02	0.18	0.29	Upgrade
EBT Excluding Unusual Items	-101.76	-100.7	-84.12	-78.72	-48.86	-26.88	Upgrade
Pretax Income	-101.76	-100.7	-89.12	-78.72	-73.7	-26.88	Upgrade
Net Income	-101.76	-100.7	-89.12	-78.72	-73.7	-26.88	Upgrade
Net Income to Common	-101.76	-100.7	-89.12	-78.72	-73.7	-26.88	Upgrade
Shares Outstanding (Basic)	57	51	40	38	22	2	Upgrade
Shares Outstanding (Diluted)	57	51	40	38	22	2	Upgrade
Shares Change (YoY)	38.83%	29.75%	4.48%	72.97%	1055.26%	9.53%	Upgrade
EPS (Basic)	-1.78	-1.96	-2.25	-2.07	-3.36	-14.15	Upgrade
EPS (Diluted)	-1.78	-1.96	-2.25	-2.07	-3.36	-14.15	Upgrade
Free Cash Flow	-96	-86.54	-77.22	-60.48	-45.94	-24.3	Upgrade
Free Cash Flow Per Share	-1.68	-1.68	-1.95	-1.59	-2.09	-12.79	Upgrade
EBITDA	-113.05	-109.75	-85.8	-77.97	-48.37	-27.54	Upgrade
D&A For EBITDA	1.04	1.03	0.97	0.9	0.97	1.03	Upgrade
EBIT	-114.09	-110.78	-86.77	-78.87	-49.34	-28.57	Upgrade

Source: S&P Capital IQ. Standard template.